PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"34910859","Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico","Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group.","N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15.","Dunkle LM","N Engl J Med","2022","2021/12/15","PMC8693692","","10.1056/NEJMoa2116185"
"33761206","Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults","Gray GE, Bekker LG, Laher F, Malahleha M, Allen M, Moodie Z, Grunenberg N, Huang Y, Grove D, Prigmore B, Kee JJ, Benkeser D, Hural J, Innes C, Lazarus E, Meintjes G, Naicker N, Kalonji D, Nchabeleng M, Sebe M, Singh N, Kotze P, Kassim S, Dubula T, Naicker V, Brumskine W, Ncayiya CN, Ward AM, Garrett N, Kistnasami G, Gaffoor Z, Selepe P, Makhoba PB, Mathebula MP, Mda P, Adonis T, Mapetla KS, Modibedi B, Philip T, Kobane G, Bentley C, Ramirez S, Takuva S, Jones M, Sikhosana M, Atujuna M, Andrasik M, Hejazi NS, Puren A, Wiesner L, Phogat S, Diaz Granados C, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, McElrath MJ, Gilbert PB, Janes H, Corey L; HVTN 702 Study Team.","N Engl J Med. 2021 Mar 25;384(12):1089-1100. doi: 10.1056/NEJMoa2031499.","Gray GE","N Engl J Med","2021","2021/03/24","PMC7888373","","10.1056/NEJMoa2031499"
"33090877","Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials","Mehrotra DV, Janes HE, Fleming TR, Annunziato PW, Neuzil KM, Carpp LN, Benkeser D, Brown ER, Carone M, Cho I, Donnell D, Fay MP, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Juraska M, Luedtke A, Nason M, Vandebosch A, Zhou H, Cohen MS, Corey L, Hartzel J, Follmann D, Gilbert PB.","Ann Intern Med. 2021 Feb;174(2):221-228. doi: 10.7326/M20-6169. Epub 2020 Oct 22.","Mehrotra DV","Ann Intern Med","2021","2020/10/22","PMC7596738","","10.7326/M20-6169"
"33730454","Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition","Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams.","N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738.","Corey L","N Engl J Med","2021","2021/03/17","PMC8189692","NIHMS1701559","10.1056/NEJMoa2031738"
"35758878","Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk","Moodie Z, Dintwe O, Sawant S, Grove D, Huang Y, Janes H, Heptinstall J, Omar FL, Cohen K, De Rosa SC, Zhang L, Yates NL, Sarzotti-Kelsoe M, Seaton KE, Laher F, Bekker LG, Malahleha M, Innes C, Kassim S, Naicker N, Govender V, Sebe M, Singh N, Kotze P, Lazarus E, Nchabeleng M, Ward AM, Brumskine W, Dubula T, Randhawa AK, Grunenberg N, Hural J, Kee JJ, Benkeser D, Jin Y, Carpp LN, Allen M, D'Souza P, Tartaglia J, DiazGranados CA, Koutsoukos M, Gilbert PB, Kublin JG, Corey L, Andersen-Nissen E, Gray GE, Tomaras GD, McElrath MJ.","J Infect Dis. 2022 Aug 24;226(2):246-257. doi: 10.1093/infdis/jiac260.","Moodie Z","J Infect Dis","2022","2022/06/27","PMC9890908","","10.1093/infdis/jiac260"
"23193203","Comparability and reproducibility of biomedical data","Huang Y, Gottardo R.","Brief Bioinform. 2013 Jul;14(4):391-401. doi: 10.1093/bib/bbs078. Epub 2012 Nov 27.","Huang Y","Brief Bioinform","2013","2012/11/30","PMC3713713","","10.1093/bib/bbs078"
"26827165","Selection of HIV vaccine candidates for concurrent testing in an efficacy trial","Huang Y, DiazGranados C, Janes H, Huang Y, deCamp AC, Metch B, Grant S, Sanchez B, Phogat S, Koutsoukos M, Kanesa-Thasan N, Bourguignon P, Collard A, Buchbinder S, Tomaras GD, McElrath J, Gray G, Kublin JG, Corey L, Gilbert PB.","Curr Opin Virol. 2016 Apr;17:57-65. doi: 10.1016/j.coviro.2016.01.007. Epub 2016 Jan 29.","Huang Y","Curr Opin Virol","2016","2016/02/01","PMC4902743","NIHMS756136","10.1016/j.coviro.2016.01.007"
"23872613","New clinical trial designs for HIV vaccine evaluation","Moodie Z, Janes H, Huang Y.","Curr Opin HIV AIDS. 2013 Sep;8(5):437-42. doi: 10.1097/COH.0b013e328363d46a.","Moodie Z","Curr Opin HIV AIDS","2013","2013/07/23","PMC3872029","NIHMS533773","10.1097/COH.0b013e328363d46a"
"35353885","High Asymptomatic Carriage With the Omicron Variant in South Africa","Garrett N, Tapley A, Andriesen J, Seocharan I, Fisher LH, Bunts L, Espy N, Wallis CL, Randhawa AK, Miner MD, Ketter N, Yacovone M, Goga A, Huang Y, Hural J, Kotze P, Bekker LG, Gray GE, Corey L; Ubuntu Study Team.","Clin Infect Dis. 2022 Aug 24;75(1):e289-e292. doi: 10.1093/cid/ciac237.","Garrett N","Clin Infect Dis","2022","2022/03/30","PMC9383623","","10.1093/cid/ciac237"
"36658109","Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial","Fong Y, Huang Y, Benkeser D, Carpp LN, Áñez G, Woo W, McGarry A, Dunkle LM, Cho I, Houchens CR, Martins K, Jayashankar L, Castellino F, Petropoulos CJ, Leith A, Haugaard D, Webb B, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Randhawa AK, Andrasik MP, Kublin JG, Hutter J, Keshtkar-Jahromi M, Beresnev TH, Corey L, Neuzil KM, Follmann D, Ake JA, Gay CL, Kotloff KL, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team; United States Government (USG)/CoVPN Biostatistics Team.","Nat Commun. 2023 Jan 19;14(1):331. doi: 10.1038/s41467-022-35768-3.","Fong Y","Nat Commun","2023","2023/01/19","PMC9851580","","10.1038/s41467-022-35768-3"
"36949083","Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial","Fong Y, Huang Y, Benkeser D, Carpp LN, Áñez G, Woo W, McGarry A, Dunkle LM, Cho I, Houchens CR, Martins K, Jayashankar L, Castellino F, Petropoulos CJ, Leith A, Haugaard D, Webb B, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Randhawa AK, Andrasik MP, Kublin JG, Hutter J, Keshtkar-Jahromi M, Beresnev TH, Corey L, Neuzil KM, Follmann D, Ake JA, Gay CL, Kotloff KL, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team; United States Government (USG)/CoVPN Biostatistics Team.","Nat Commun. 2023 Mar 22;14(1):1581. doi: 10.1038/s41467-023-37367-2.","Fong Y","Nat Commun","2023","2023/03/23","PMC10031713","","10.1038/s41467-023-37367-2"
"35995954","Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition","Gilbert PB, Huang Y, deCamp AC, Karuna S, Zhang Y, Magaret CA, Giorgi EE, Korber B, Edlefsen PT, Rossenkhan R, Juraska M, Rudnicki E, Kochar N, Huang Y, Carpp LN, Barouch DH, Mkhize NN, Hermanus T, Kgagudi P, Bekker V, Kaldine H, Mapengo RE, Eaton A, Domin E, West C, Feng W, Tang H, Seaton KE, Heptinstall J, Brackett C, Chiong K, Tomaras GD, Andrew P, Mayer BT, Reeves DB, Sobieszczyk ME, Garrett N, Sanchez J, Gay C, Makhema J, Williamson C, Mullins JI, Hural J, Cohen MS, Corey L, Montefiori DC, Morris L.","Nat Med. 2022 Sep;28(9):1924-1932. doi: 10.1038/s41591-022-01953-6. Epub 2022 Aug 22.","Gilbert PB","Nat Med","2022","2022/08/22","PMC9499869","","10.1038/s41591-022-01953-6"
"35385469","Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention","Mayer BT, deCamp AC, Huang Y, Schiffer JT, Gottardo R, Gilbert PB, Reeves DB.","PLoS Comput Biol. 2022 Apr 6;18(4):e1010003. doi: 10.1371/journal.pcbi.1010003. eCollection 2022 Apr.","Mayer BT","PLoS Comput Biol","2022","2022/04/06","PMC9084525","","10.1371/journal.pcbi.1010003"
"33859204","Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans","Seaton KE, Deal A, Han X, Li SS, Clayton A, Heptinstall J, Duerr A, Allen MA, Shen X, Sawant S, Yates NL, Spearman P, Churchyard G, Goepfert PA, Maenza J, Gray G, Pantaleo G, Polakowski L, Robinson HL, Grant S, Randhawa AK, Huang Y, Morgan C, Grunenberg N, Karuna S, Gilbert PB, McElrath MJ, Huang Y, Tomaras GD; NIAID HIV Vaccine Trials Network (HVTN) 076, 088, 086, 096, 097, 205 Study Teams.","NPJ Vaccines. 2021 Apr 15;6(1):56. doi: 10.1038/s41541-021-00305-8.","Seaton KE","NPJ Vaccines","2021","2021/04/16","PMC8050318","","10.1038/s41541-021-00305-8"
"34907214","Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation","Huang Y, Borisov O, Kee JJ, Carpp LN, Wrin T, Cai S, Sarzotti-Kelsoe M, McDanal C, Eaton A, Pajon R, Hural J, Posavad CM, Gill K, Karuna S, Corey L, McElrath MJ, Gilbert PB, Petropoulos CJ, Montefiori DC.","Sci Rep. 2021 Dec 14;11(1):23921. doi: 10.1038/s41598-021-03154-6.","Huang Y","Sci Rep","2021","2021/12/15","PMC8671391","","10.1038/s41598-021-03154-6"
"34494017","Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation","Huang Y, Borisov O, Kee JJ, Carpp LN, Wrin T, Cai S, Sarzotti-Kelsoe M, McDanal C, Eaton A, Pajon R, Hural J, Posavad CM, Gill K, Karuna S, Corey L, McElrath MJ, Gilbert PB, Petropoulos CJ, Montefiori DC.","Res Sq. 2021 Sep 2:rs.3.rs-862572. doi: 10.21203/rs.3.rs-862572/v1. Preprint.","Huang Y","Res Sq","2021","2021/09/08","PMC8423224","","10.21203/rs.3.rs-862572/v1"
"36684526","Simulation-Based Pharmacokinetics Sampling Design for Evaluating Correlates of Prevention Efficacy of Passive HIV Monoclonal Antibody Prophylaxis","Zhang L, Gilbert PB, Capparelli E, Huang Y.","Stat Biopharm Res. 2022;14(4):611-625. doi: 10.1080/19466315.2021.1919196. Epub 2021 Jun 28.","Zhang L","Stat Biopharm Res","2022","2023/01/23","PMC9856202","NIHMS1757617","10.1080/19466315.2021.1919196"
"36689221","Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials","Mena Lora AJ, Long JE, Huang Y, Baden LR, El Sahly HM, Follmann D, Goepfert P, Gray G, Grinsztejn B, Kotloff K, Rouphael N, Sobieszczyk M, Walsh SR, Andriesen J, Shah KA, Zhang Y, Gilbert P, Janes H, Gay CL, Falsey AR, Tripp RL, Gorman RL, Tong T, Marovich M, Neuzil K, Corey L, Kublin JG; COVID-19 Prevention Network.","JAMA Netw Open. 2023 Jan 3;6(1):e2251974. doi: 10.1001/jamanetworkopen.2022.51974.","Mena Lora AJ","JAMA Netw Open","2023","2023/01/23","","","10.1001/jamanetworkopen.2022.51974"
"25454855","Use of placebos in Phase 1 preventive HIV vaccine clinical trials","Huang Y, Karuna ST, Janes H, Frahm N, Nason M, Edlefsen PT, Kublin JG, Corey L, McElrath MJ, Gilbert PB.","Vaccine. 2015 Feb 4;33(6):749-52. doi: 10.1016/j.vaccine.2014.10.017. Epub 2014 Oct 23.","Huang Y","Vaccine","2015","2014/12/03","PMC4554766","NIHMS715614","10.1016/j.vaccine.2014.10.017"
"37018240","Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa","Mashingaidze R, Moodie Z, Allen M, Bekker LG, Grove D, Grunenberg N, Huang Y, Janes HE, Lazarus EM, Malahleha M, Nchabeleng M, Laher F.","PLOS Glob Public Health. 2023 Apr 5;3(4):e0001782. doi: 10.1371/journal.pgph.0001782. eCollection 2023.","Mashingaidze R","PLOS Glob Public Health","2023","2023/04/05","PMC10075439","","10.1371/journal.pgph.0001782"
"34545372","Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation","Huang Y, Borisov O, Kee JJ, Carpp LN, Wrin T, Cai S, Sarzotti-Kelsoe M, McDanal C, Eaton A, Pajon R, Hural J, Posavad CM, Gill K, Karuna S, Corey L, McElrath MJ, Gilbert PB, Petropoulos CJ, Montefiori DC.","medRxiv. 2021 Sep 14:2021.09.09.21263049. doi: 10.1101/2021.09.09.21263049. Preprint.","Huang Y","medRxiv","2021","2021/09/21","PMC8452111","","10.1101/2021.09.09.21263049"
"37384759","Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials","Mkhize NN, Yssel AEJ, Kaldine H, van Dorsten RT, Woodward Davis AS, Beaume N, Matten D, Lambson B, Modise T, Kgagudi P, York T, Westfall DH, Giorgi EE, Korber B, Anthony C, Mapengo RE, Bekker V, Domin E, Eaton A, Deng W, DeCamp A, Huang Y, Gilbert PB, Gwashu-Nyangiwe A, Thebus R, Ndabambi N, Mielke D, Mgodi N, Karuna S, Edupuganti S, Seaman MS, Corey L, Cohen MS, Hural J, McElrath MJ, Mullins JI, Montefiori D, Moore PL, Williamson C, Morris L.","PLoS Pathog. 2023 Jun 29;19(6):e1011469. doi: 10.1371/journal.ppat.1011469. eCollection 2023 Jun.","Mkhize NN","PLoS Pathog","2023","2023/06/29","PMC10337935","","10.1371/journal.ppat.1011469"
"34707608","Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies","Hou J, Wang S, Li D, Carpp LN, Zhang T, Liu Y, Jia M, Peng H, Liu C, Wu H, Huang Y, Shao Y.","Front Immunol. 2021 Oct 11;12:737487. doi: 10.3389/fimmu.2021.737487. eCollection 2021.","Hou J","Front Immunol","2021","2021/10/28","PMC8542877","","10.3389/fimmu.2021.737487"
"36179551","Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens","Huang Y, Zhang Y, Seaton KE, De Rosa S, Heptinstall J, Carpp LN, Randhawa AK, McKinnon LR, McLaren P, Viegas E, Gray GE, Churchyard G, Buchbinder SP, Edupuganti S, Bekker LG, Keefer MC, Hosseinipour MC, Goepfert PA, Cohen KW, Williamson BD, McElrath MJ, Tomaras GD, Thakar J, Kobie JJ; NIAID HIV Vaccine Trials Network (HVTN) 073/South African AIDS Vaccine Initiative (SAAVI) 102, HVTN 086/SAAVI 103, HVTN 094, HVTN 097, HVTN 098, HVTN 100, HVTN 105, HVTN 111, and HVTN 205 Protocol Leadership Teams.","EBioMedicine. 2022 Oct;84:104271. doi: 10.1016/j.ebiom.2022.104271. Epub 2022 Sep 27.","Huang Y","EBioMedicine","2022","2022/09/30","PMC9520208","","10.1016/j.ebiom.2022.104271"
"37385888","Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials","Turley CB, Tables L, Fuller T, Sanders LJ, Scott H, Moodley A, Woodward Davis A, Leav B, Miller J, Schoemaker K, Vandebosch A, Sadoff J, Woo W, Cho I, Dunkle LM, Li S, van der Laan L, Gilbert PB, Follmann D, Jaynes H, Kublin JG, Baden LR, Goepfert P, Kotloff K, Gay CL, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Rouphael N, Luedtke A; COVID-19 Prevention Network CoVPN.","Vaccine. 2023 Jul 25;41(33):4899-4906. doi: 10.1016/j.vaccine.2023.06.066. Epub 2023 Jun 23.","Turley CB","Vaccine","2023","2023/06/29","PMC10288314","","10.1016/j.vaccine.2023.06.066"
"26826543","A case for preART-adjusted endpoints in HIV therapeutic vaccine trials","Huang Y, Zhang L, Jolliffe D, Hovden AO, Ökvist M, Pantaleo G, Sommerfelt MA.","Vaccine. 2016 Mar 4;34(10):1282-8. doi: 10.1016/j.vaccine.2016.01.025. Epub 2016 Jan 27.","Huang Y","Vaccine","2016","2016/01/31","","","10.1016/j.vaccine.2016.01.025"
"31313349","Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trials","Gilbert PB, Zhang Y, Rudnicki E, Huang Y.","Stat Med. 2019 Oct 15;38(23):4503-4518. doi: 10.1002/sim.8310. Epub 2019 Jul 17.","Gilbert PB","Stat Med","2019","2019/07/18","PMC6736712","NIHMS1037312","10.1002/sim.8310"
"33493795","Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials","Huang Y, Naidoo L, Zhang L, Carpp LN, Rudnicki E, Randhawa A, Gonzales P, McDermott A, Ledgerwood J, Lorenzo MMG, Burns D, DeCamp A, Juraska M, Mascola J, Edupuganti S, Mgodi N, Cohen M, Corey L, Andrew P, Karuna S, Gilbert PB, Mngadi K, Lazarus E.","EBioMedicine. 2021 Feb;64:103203. doi: 10.1016/j.ebiom.2020.103203. Epub 2021 Jan 23.","Huang Y","EBioMedicine","2021","2021/01/25","PMC7841500","","10.1016/j.ebiom.2020.103203"
"32421033","Generating Survival Times Using Cox Proportional Hazards Models with Cyclic and Piecewise Time-Varying Covariates","Huang Y, Zhang Y, Zhang Z, Gilbert PB.","Stat Biosci. 2020;12(3):324-339. doi: 10.1007/s12561-020-09266-3. Epub 2020 Jan 25.","Huang Y","Stat Biosci","2020","2020/05/19","PMC7223425","","10.1007/s12561-020-09266-3"
"35866633","A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats","Longini IM, Yang Y, Fleming TR, Muñoz-Fontela C, Wang R, Ellenberg SS, Qian G, Halloran ME, Nason M, Gruttola V, Mulangu S, Huang Y, Donnelly CA, Henao Restrepo AM.","Clin Trials. 2022 Dec;19(6):647-654. doi: 10.1177/17407745221110880. Epub 2022 Jul 22.","Longini IM","Clin Trials","2022","2022/07/22","PMC9679315","NIHMS1816966","10.1177/17407745221110880"
"34213402","Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants","Huang Y, Zhang L, Eaton A, Mkhize NN, Carpp LN, Rudnicki E, DeCamp A, Juraska M, Randhawa A, McDermott A, Ledgerwood J, Andrew P, Karuna S, Edupuganti S, Mgodi N, Cohen M, Corey L, Mascola J, Gilbert PB, Morris L, Montefiori DC.","Hum Vaccin Immunother. 2022 Dec 31;18(1):1908030. doi: 10.1080/21645515.2021.1908030. Epub 2021 Jul 2.","Huang Y","Hum Vaccin Immunother","2022","2021/07/02","PMC8928800","","10.1080/21645515.2021.1908030"
"37300931","Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition","Seaton KE, Huang Y, Karuna S, Heptinstall JR, Brackett C, Chiong K, Zhang L, Yates NL, Sampson M, Rudnicki E, Juraska M, deCamp AC, Edlefsen PT, Mullins JI, Williamson C, Rossenkhan R, Giorgi EE, Kenny A, Angier H, Randhawa A, Weiner JA, Rojas M, Sarzotti-Kelsoe M, Zhang L, Sawant S, Ackerman ME, McDermott AB, Mascola JR, Hural J, McElrath MJ, Andrew P, Hidalgo JA, Clark J, Laher F, Orrell C, Frank I, Gonzales P, Edupuganti S, Mgodi N, Corey L, Morris L, Montefiori D, Cohen MS, Gilbert PB, Tomaras GD.","EBioMedicine. 2023 Jul;93:104590. doi: 10.1016/j.ebiom.2023.104590. Epub 2023 Jun 8.","Seaton KE","EBioMedicine","2023","2023/06/10","PMC10363420","","10.1016/j.ebiom.2023.104590"
"35866359","Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responses","Dintwe OB, De Rosa SC, Huang Y, Flach BS, Manso B, Carter D, Omar FL, Schwedhelm KV, Yu C, Lu H, Morris D, Kee JJ, Voillet V, Stirewalt M, Hural J, Moodie Z, Frahm N, Cohen KW, McElrath MJ, Andersen-Nissen E.","J Leukoc Biol. 2022 Nov;112(5):1167-1181. doi: 10.1002/JLB.5MA0522-668R. Epub 2022 Jul 22.","Dintwe OB","J Leukoc Biol","2022","2022/07/22","PMC10229754","NIHMS1894529","10.1002/JLB.5MA0522-668R"
"34157979","Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study","Yue Y, Li Y, Cui Y, Wang N, Huang Y, Cao W, Han Y, Zhu T, Lyu W, Xie J, Song X, Li Y, Wang T, Zhu T, Li T.","BMC Infect Dis. 2021 Jun 22;21(1):592. doi: 10.1186/s12879-021-06267-5.","Yue Y","BMC Infect Dis","2021","2021/06/23","PMC8218450","","10.1186/s12879-021-06267-5"
"37289667","Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants","Espy N, Han X, Grant S, Kwara E, Lakshminarayanan B, Stirewalt M, Seaton KE, Tomaras GD, Goecker E, McElrath J, Andriesen J, Huang Y, Walsh SR, Hural J.","PLOS Glob Public Health. 2023 Jun 8;3(6):e0002037. doi: 10.1371/journal.pgph.0002037. eCollection 2023.","Espy N","PLOS Glob Public Health","2023","2023/06/08","PMC10249892","","10.1371/journal.pgph.0002037"
"32437332","Robust antibody and cellular responses induced by DNA-only vaccination for HIV","De Rosa SC, Edupuganti S, Huang Y, Han X, Elizaga M, Swann E, Polakowski L, Kalams SA, Keefer MC, Maenza J, Lu Y, Wise MC, Yan J, Morrow MP, Khan AS, Boyer JD, Humeau L, White S, Pensiero M, Sardesai NY, Bagarazzi ML, Weiner DB, Ferrari G, Tomaras GD, Montefiori DC, Corey L, McElrath MJ; HIV Vaccine Trials Network (HVTN) 098 Study Team.","JCI Insight. 2020 Jul 9;5(13):e137079. doi: 10.1172/jci.insight.137079.","De Rosa SC","JCI Insight","2020","2020/05/22","PMC7406303","","10.1172/jci.insight.137079"
"33844575","A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated","Follmann D, Fintzi J, Fay MP, Janes HE, Baden LR, El Sahly HM, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM.","Ann Intern Med. 2021 Aug;174(8):1118-1125. doi: 10.7326/M20-8149. Epub 2021 Apr 13.","Follmann D","Ann Intern Med","2021","2021/04/12","PMC8099035","","10.7326/M20-8149"
"29594618","Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa","Dietrich JJ, Lazarus E, Andrasik M, Hornschuh S, Otwombe K, Morgan C, Isaacs AJ, Huang Y, Laher F, Kublin JG, Gray GE; HVTN 915 study team.","AIDS Behav. 2018 Jul;22(7):2312-2321. doi: 10.1007/s10461-018-2080-y.","Dietrich JJ","AIDS Behav","2018","2018/03/30","PMC6176864","NIHMS962370","10.1007/s10461-018-2080-y"
"36929319","Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa","Malahleha M, Laher F, Dilraj A, Smith P, Gray GE, Grove D, Odhiambo JA, Andrasik MP, Grunenberg NA, Moodie Z, Huang Y, Borate BR, Gillespie KM, Allen M, Atujuna M, Singh N, Kalonji D, Meintjes G, Kotze P, Bekker LG, Janes H.","AIDS Behav. 2023 Sep;27(9):3027-3037. doi: 10.1007/s10461-023-04025-z. Epub 2023 Mar 16.","Malahleha M","AIDS Behav","2023","2023/03/17","PMC10386918","","10.1007/s10461-023-04025-z"
"28368743","Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults","Huang Y, Zhang L, Ledgerwood J, Grunenberg N, Bailer R, Isaacs A, Seaton K, Mayer KH, Capparelli E, Corey L, Gilbert PB.","MAbs. 2017 Jul;9(5):792-800. doi: 10.1080/19420862.2017.1311435. Epub 2017 Apr 3.","Huang Y","MAbs","2017","2017/04/04","PMC5524155","","10.1080/19420862.2017.1311435"
"21709567","Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target-specific regions of HIV-1","Friedrich D, Jalbert E, Dinges WL, Sidney J, Sette A, Huang Y, McElrath MJ, Horton H.","J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):248-52. doi: 10.1097/QAI.0b013e318228f992.","Friedrich D","J Acquir Immune Defic Syndr","2011","2011/06/29","PMC3196811","NIHMS311971","10.1097/QAI.0b013e318228f992"
"29683765","Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials","Huang Y, Karuna S, Carpp LN, Reeves D, Pegu A, Seaton K, Mayer K, Schiffer J, Mascola J, Gilbert PB.","Hum Vaccin Immunother. 2018;14(9):2116-2127. doi: 10.1080/21645515.2018.1462640. Epub 2018 May 24.","Huang Y","Hum Vaccin Immunother","2018","2018/04/24","PMC6183277","","10.1080/21645515.2018.1462640"
"31855881","Brief Report: Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01","Huang Y, Zhang Y, Bailer R, Grunenberg N, Carpp LN, Seaton K, Mayer KH, Ledgerwood J, Corey L, Mascola J, Montefiori D, Gilbert PB.","J Acquir Immune Defic Syndr. 2020 Apr 1;83(4):434-439. doi: 10.1097/QAI.0000000000002272.","Huang Y","J Acquir Immune Defic Syndr","2020","2019/12/20","PMC7594341","NIHMS1549606","10.1097/QAI.0000000000002272"
"31748227","Antigenic competition in CD4(+) T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial","Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Van Tieu H, Allen M, Hural J, Graham BS, Kublin J, Gilbert PB, Corey L, Goepfert PA, McElrath MJ, Johnson RP, Huang Y, Frahm N.","Sci Transl Med. 2019 Nov 20;11(519):eaaw1673. doi: 10.1126/scitranslmed.aaw1673.","Kallas EG","Sci Transl Med","2019","2019/11/22","PMC7003991","NIHMS1062357","10.1126/scitranslmed.aaw1673"
"27037797","Power/sample size calculations for assessing correlates of risk in clinical efficacy trials","Gilbert PB, Janes HE, Huang Y.","Stat Med. 2016 Sep 20;35(21):3745-59. doi: 10.1002/sim.6952. Epub 2016 Mar 31.","Gilbert PB","Stat Med","2016","2016/04/03","PMC4965346","NIHMS773751","10.1002/sim.6952"
"33336213","Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials","Follmann D, Fintzi J, Fay MP, Janes HE, Baden L, Sahly HE, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM.","medRxiv. 2020 Dec 14:2020.12.14.20248137. doi: 10.1101/2020.12.14.20248137. Preprint.","Follmann D","medRxiv","2020","2020/12/18","PMC7745130","","10.1101/2020.12.14.20248137"
"28131393","Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials","Huang Y, Zhang L, Janes H, Frahm N, Isaacs A, Kim JH, Montefiori D, McElrath MJ, Tomaras GD, Gilbert PB.","Vaccine. 2017 Feb 22;35(8):1184-1193. doi: 10.1016/j.vaccine.2016.09.053. Epub 2017 Jan 25.","Huang Y","Vaccine","2017","2017/01/30","PMC5319823","NIHMS842454","10.1016/j.vaccine.2016.09.053"
"32747654","Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature","Palli R, Seaton KE, Piepenbrink MS, Hural J, Goepfert PA, Laher F, Buchbinder SP, Churchyard G, Gray GE, Robinson HL, Huang Y, Janes H, Kobie JJ, Keefer MC, Tomaras GD, Thakar J.","Sci Rep. 2020 Aug 3;10(1):13031. doi: 10.1038/s41598-020-69007-w.","Palli R","Sci Rep","2020","2020/08/05","PMC7398916","","10.1038/s41598-020-69007-w"
"32084132","Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials","Reeves DB, Huang Y, Duke ER, Mayer BT, Cardozo-Ojeda EF, Boshier FA, Swan DA, Rolland M, Robb ML, Mascola JR, Cohen MS, Corey L, Gilbert PB, Schiffer JT.","PLoS Comput Biol. 2020 Feb 21;16(2):e1007626. doi: 10.1371/journal.pcbi.1007626. eCollection 2020 Feb.","Reeves DB","PLoS Comput Biol","2020","2020/02/22","PMC7055956","","10.1371/journal.pcbi.1007626"
"31513771","A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge","Pegu A, Borate B, Huang Y, Pauthner MG, Hessell AJ, Julg B, Doria-Rose NA, Schmidt SD, Carpp LN, Cully MD, Chen X, Shaw GM, Barouch DH, Haigwood NL, Corey L, Burton DR, Roederer M, Gilbert PB, Mascola JR, Huang Y.","Cell Host Microbe. 2019 Sep 11;26(3):336-346.e3. doi: 10.1016/j.chom.2019.08.014.","Pegu A","Cell Host Microbe","2019","2019/09/13","PMC6755677","NIHMS1539171","10.1016/j.chom.2019.08.014"
"27913647","Diversity of Antiviral IgG Effector Activities Observed in HIV-Infected and Vaccinated Subjects","Huang Y, Ferrari G, Alter G, Forthal DN, Kappes JC, Lewis GK, Love JC, Borate B, Harris L, Greene K, Gao H, Phan TB, Landucci G, Goods BA, Dowell KG, Cheng HD, Bailey-Kellogg C, Montefiori DC, Ackerman ME.","J Immunol. 2016 Dec 15;197(12):4603-4612. doi: 10.4049/jimmunol.1601197. Epub 2016 Nov 9.","Huang Y","J Immunol","2016","2016/12/04","PMC5137799","NIHMS824957","10.4049/jimmunol.1601197"
"34166231","Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge","Astronomo RD, Lemos MP, Narpala SR, Czartoski J, Fleming LB, Seaton KE, Prabhakaran M, Huang Y, Lu Y, Westerberg K, Zhang L, Gross MK, Hural J, Tieu HV, Baden LR, Hammer S, Frank I, Ochsenbauer C, Grunenberg N, Ledgerwood JE, Mayer K, Tomaras G, McDermott AB, McElrath MJ.","J Clin Invest. 2021 Aug 16;131(16):e146975. doi: 10.1172/JCI146975.","Astronomo RD","J Clin Invest","2021","2021/06/24","PMC8363291","","10.1172/JCI146975"
"31277299","Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-infection Estimation towards Enhanced Vaccine Efficacy Assessment","Rossenkhan R, Rolland M, Labuschagne JPL, Ferreira RC, Magaret CA, Carpp LN, Matsen Iv FA, Huang Y, Rudnicki EE, Zhang Y, Ndabambi N, Logan M, Holzman T, Abrahams MR, Anthony C, Tovanabutra S, Warth C, Botha G, Matten D, Nitayaphan S, Kibuuka H, Sawe FK, Chopera D, Eller LA, Travers S, Robb ML, Williamson C, Gilbert PB, Edlefsen PT.","Viruses. 2019 Jul 3;11(7):607. doi: 10.3390/v11070607.","Rossenkhan R","Viruses","2019","2019/07/07","PMC6669737","","10.3390/v11070607"
"34229888","AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period","Huang Y, Seaton KE, Casapia M, Polakowski L, De Rosa SC, Cohen K, Yu C, Elizaga M, Paez C, Miner MD, Kelley CF, Maenza J, Keefer M, Lama JR, Sobieszczyk M, Buchbinder S, Baden LR, Lee C, Gulati V, Sinangil F, Montefiori D, McElrath MJ, Tomaras GD, Robinson HL, Goepfert P; NIAID-funded HIV Vaccine Trials Network (HVTN) 114 Study Team.","Vaccine. 2021 Jul 30;39(33):4641-4650. doi: 10.1016/j.vaccine.2021.06.066. Epub 2021 Jul 3.","Huang Y","Vaccine","2021","2021/07/07","PMC8853668","NIHMS1721643","10.1016/j.vaccine.2021.06.066"
"36404417","Comparing and combining data from immune assays based on left-censored multivariate normal model assuming common assay differences across settings","Huang Y, Huang Y.","Stat Med. 2023 Jan 30;42(2):164-177. doi: 10.1002/sim.9607. Epub 2022 Nov 20.","Huang Y","Stat Med","2023","2022/11/21","PMC9790822","NIHMS1848923","10.1002/sim.9607"
"37440227","Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials","Theodore DA, Branche AR, Zhang L, Graciaa DS, Choudhary M, Hatlen TJ, Osman R, Babu TM, Robinson ST, Gilbert PB, Follmann D, Janes H, Kublin JG, Baden LR, Goepfert P, Gray GE, Grinsztejn B, Kotloff KL, Gay CL, Leav B, Miller J, Hirsch I, Sadoff J, Dunkle LM, Neuzil KM, Corey L, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y; COVID-19 Prevention Network (CoVPN).","JAMA Netw Open. 2023 Jul 3;6(7):e2323349. doi: 10.1001/jamanetworkopen.2023.23349.","Theodore DA","JAMA Netw Open","2023","2023/07/13","PMC10346130","","10.1001/jamanetworkopen.2023.23349"
"33297341","Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP(®) DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults","Edupuganti S, C De Rosa S, Elizaga M, Lu Y, Han X, Huang Y, Swann E, Polakowski L, A Kalams S, Keefer M, Maenza J, C Wise M, Yan J, Morrow MP, Khan AS, Boyer JD, Humeau L, White S, Sardesai NY, Bagarazzi ML, Gilbert PB, Kublin JG, Corey L, Weiner DB, On Behalf Of The Hvtn Study Team, The Niaid-Funded Hiv Vaccine Trials Network.","Vaccines (Basel). 2020 Dec 7;8(4):741. doi: 10.3390/vaccines8040741.","Edupuganti S","Vaccines (Basel)","2020","2020/12/10","PMC7762306","","10.3390/vaccines8040741"
"29218117","Basis and Statistical Design of the Passive HIV-1 Antibody Mediated Prevention (AMP) Test-of-Concept Efficacy Trials","Gilbert PB, Juraska M, deCamp AC, Karuna S, Edupuganti S, Mgodi N, Donnell DJ, Bentley C, Sista N, Andrew P, Isaacs A, Huang Y, Zhang L, Capparelli E, Kochar N, Wang J, Eshleman SH, Mayer KH, Magaret CA, Hural J, Kublin JG, Gray G, Montefiori DC, Gomez MM, Burns DN, McElrath J, Ledgerwood J, Graham BS, Mascola JR, Cohen M, Corey L.","Stat Commun Infect Dis. 2017 Jan;9(1):20160001. doi: 10.1515/scid-2016-0001. Epub 2017 Jun 6.","Gilbert PB","Stat Commun Infect Dis","2017","2017/12/09","PMC5714515","NIHMS898295","10.1515/scid-2016-0001"
"26133091","The sexually driven epidemic in youths in China's southwestern border region was caused by dynamic emerging multiple recombinant HIV-1 strains","Wei H, Xing H, Hsi JH, Jia M, Feng Y, Duan S, He C, Yao S, Ruan Y, He X, Liao L, Ma Y, Huang Y, Lu L, Shao Y.","Sci Rep. 2015 Jul 2;5:11323. doi: 10.1038/srep11323.","Wei H","Sci Rep","2015","2015/07/03","PMC4489098","","10.1038/srep11323"
"22201684","Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine","Frahm N, DeCamp AC, Friedrich DP, Carter DK, Defawe OD, Kublin JG, Casimiro DR, Duerr A, Robertson MN, Buchbinder SP, Huang Y, Spies GA, De Rosa SC, McElrath MJ.","J Clin Invest. 2012 Jan;122(1):359-67. doi: 10.1172/JCI60202. Epub 2011 Dec 27.","Frahm N","J Clin Invest","2012","2011/12/29","PMC3248307","","10.1172/JCI60202"
"22561365","Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)","Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN; Step/HVTN 504 Study Team.","J Infect Dis. 2012 Jul 15;206(2):258-66. doi: 10.1093/infdis/jis342. Epub 2012 May 4.","Duerr A","J Infect Dis","2012","2012/05/08","PMC3490694","","10.1093/infdis/jis342"
"16959262","Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials","Moodie Z, Huang Y, Gu L, Hural J, Self SG.","J Immunol Methods. 2006 Aug 31;315(1-2):121-32. doi: 10.1016/j.jim.2006.07.015. Epub 2006 Aug 15.","Moodie Z","J Immunol Methods","2006","2006/09/09","","","10.1016/j.jim.2006.07.015"
"28970080","Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial","Huang Y, Pantaleo G, Tapia G, Sanchez B, Zhang L, Trondsen M, Hovden AO, Pollard R, Rockstroh J, Ökvist M, Sommerfelt MA.","EBioMedicine. 2017 Oct;24:195-204. doi: 10.1016/j.ebiom.2017.09.028. Epub 2017 Sep 22.","Huang Y","EBioMedicine","2017","2017/10/04","PMC5652289","","10.1016/j.ebiom.2017.09.028"
"28687661","A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine","Hou J, Wang S, Jia M, Li D, Liu Y, Li Z, Zhu H, Xu H, Sun M, Lu L, Zhou Z, Peng H, Zhang Q, Fu S, Liang G, Yao L, Yu X, Carpp LN, Huang Y, McElrath J, Self S, Shao Y.","J Immunol. 2017 Aug 15;199(4):1476-1489. doi: 10.4049/jimmunol.1700083. Epub 2017 Jul 7.","Hou J","J Immunol","2017","2017/07/09","PMC6681914","NIHMS1039363","10.4049/jimmunol.1700083"
"26332672","Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials","Huang Y, Follmann D, Nason M, Zhang L, Huang Y, Mehrotra DV, Moodie Z, Metch B, Janes H, Keefer MC, Churchyard G, Robb ML, Fast PE, Duerr A, McElrath MJ, Corey L, Mascola JR, Graham BS, Sobieszczyk ME, Kublin JG, Robertson M, Hammer SM, Gray GE, Buchbinder SP, Gilbert PB.","PLoS One. 2015 Sep 2;10(9):e0136626. doi: 10.1371/journal.pone.0136626. eCollection 2015.","Huang Y","PLoS One","2015","2015/09/03","PMC4558095","","10.1371/journal.pone.0136626"
"31095007","Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915)","Lemos MP, Lazarus E, Isaacs A, Dietrich J, Morgan C, Huang Y, Grove D, Andrasik M, Laher F, Hural J, Chung E, Dragavon J, Puren A, Gulati RK, Coombs R, McElrath MJ, Gray G, Kublin JG.","J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):e39-e48. doi: 10.1097/QAI.0000000000002015.","Lemos MP","J Acquir Immune Defic Syndr","2019","2019/05/17","PMC6743720","NIHMS1522010","10.1097/QAI.0000000000002015"
"31473167","Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial","Gaudinski MR, Houser KV, Doria-Rose NA, Chen GL, Rothwell RSS, Berkowitz N, Costner P, Holman LA, Gordon IJ, Hendel CS, Kaltovich F, Conan-Cibotti M, Gomez Lorenzo M, Carter C, Sitar S, Carlton K, Gall J, Laurencot C, Lin BC, Bailer RT, McDermott AB, Ko SY, Pegu A, Kwon YD, Kwong PD, Namboodiri AM, Pandey JP, Schwartz R, Arnold F, Hu Z, Zhang L, Huang Y, Koup RA, Capparelli EV, Graham BS, Mascola JR, Ledgerwood JE; VRC 605 study team.","Lancet HIV. 2019 Oct;6(10):e667-e679. doi: 10.1016/S2352-3018(19)30181-X. Epub 2019 Aug 28.","Gaudinski MR","Lancet HIV","2019","2019/09/02","","","10.1016/S2352-3018(19)30181-X"
"32324753","A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa","Dietrich JJ, Hornschuh S, Khunwane M, Makhale LM, Otwombe K, Morgan C, Huang Y, Lemos M, Lazarus E, Kublin JG, Gray GE, Laher F, Andrasik M; HVTN 915 team.","PLoS One. 2020 Apr 23;15(4):e0231086. doi: 10.1371/journal.pone.0231086. eCollection 2020.","Dietrich JJ","PLoS One","2020","2020/04/24","PMC7179867","","10.1371/journal.pone.0231086"
"29297230","Postvaccination C-Reactive Protein and C5/gp41(732-744) Antibody Level Fold-Changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x","Huang Y, Zhang L, Jolliffe D, Sanchez B, Stjernholm G, Jelmert Ø, Ökvist M, Sommerfelt MA.","AIDS Res Hum Retroviruses. 2018 Mar;34(3):307-313. doi: 10.1089/AID.2017.0179. Epub 2018 Feb 13.","Huang Y","AIDS Res Hum Retroviruses","2018","2018/01/04","","","10.1089/AID.2017.0179"
"25369172","Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study","Huang Y, Duerr A, Frahm N, Zhang L, Moodie Z, De Rosa S, McElrath MJ, Gilbert PB.","PLoS One. 2014 Nov 4;9(11):e108631. doi: 10.1371/journal.pone.0108631. eCollection 2014.","Huang Y","PLoS One","2014","2014/11/05","PMC4219669","","10.1371/journal.pone.0108631"
"28727817","Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults","Buchbinder SP, Grunenberg NA, Sanchez BJ, Seaton KE, Ferrari G, Moody MA, Frahm N, Montefiori DC, Hay CM, Goepfert PA, Baden LR, Robinson HL, Yu X, Gilbert PB, McElrath MJ, Huang Y, Tomaras GD; HIV Vaccine Trials Network (HVTN) 094 Study Group.","PLoS One. 2017 Jul 20;12(7):e0179597. doi: 10.1371/journal.pone.0179597. eCollection 2017.","Buchbinder SP","PLoS One","2017","2017/07/21","PMC5519050","","10.1371/journal.pone.0179597"
"18615598","Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials","Shulman N, Bellew M, Snelling G, Carter D, Huang Y, Li H, Self SG, McElrath MJ, De Rosa SC.","Cytometry A. 2008 Sep;73(9):847-56. doi: 10.1002/cyto.a.20600.","Shulman N","Cytometry A","2008","2008/07/11","PMC2591089","NIHMS75926","10.1002/cyto.a.20600"
"17082660","Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection","Horton H, Frank I, Baydo R, Jalbert E, Penn J, Wilson S, McNevin JP, McSweyn MD, Lee D, Huang Y, De Rosa SC, McElrath MJ.","J Immunol. 2006 Nov 15;177(10):7406-15. doi: 10.4049/jimmunol.177.10.7406.","Horton H","J Immunol","2006","2006/11/04","","","10.4049/jimmunol.177.10.7406"
"21860356","Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)","Barnabas RV, Wasserheit JN, Huang Y, Janes H, Morrow R, Fuchs J, Mark KE, Casapia M, Mehrotra DV, Buchbinder SP, Corey L; NIAID HIV Vaccine Trials Network.","J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):238-44. doi: 10.1097/QAI.0b013e31821acb5.","Barnabas RV","J Acquir Immune Defic Syndr","2011","2011/08/24","PMC3446850","NIHMS349902","10.1097/QAI.0b013e31821acb5"
"17451739","Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","Horton H, Thomas EP, Stucky JA, Frank I, Moodie Z, Huang Y, Chiu YL, McElrath MJ, De Rosa SC.","J Immunol Methods. 2007 May 31;323(1):39-54. doi: 10.1016/j.jim.2007.03.002. Epub 2007 Apr 3.","Horton H","J Immunol Methods","2007","2007/04/25","PMC2683732","NIHMS24327","10.1016/j.jim.2007.03.002"
"23110243","A Comparison of Testing Parameters and the Implementation of a Group Sequential Design for Equivalence Studies Using Paired-sample Analysis","Huang Y, Self SG.","Stat Biopharm Res. 2010;2(3):336-347. doi: 10.1198/sbr.2009.08078. Epub 2012 Jan 1.","Huang Y","Stat Biopharm Res","2010","2012/10/31","PMC3481840","NIHMS408752","10.1198/sbr.2009.08078"
"29136037","Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial","Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, Bailer RT, Ferrari G, Jensen R, Hural J, Graham BS, Mascola JR, Corey L, Montefiori DC; HVTN 104 Protocol Team; and the NIAID HIV Vaccine Trials Network.","PLoS Med. 2017 Nov 14;14(11):e1002435. doi: 10.1371/journal.pmed.1002435. eCollection 2017 Nov.","Mayer KH","PLoS Med","2017","2017/11/15","PMC5685476","","10.1371/journal.pmed.1002435"
"22764070","Comparing and combining data across multiple sources via integration of paired-sample data to correct for measurement error","Huang Y, Huang Y, Moodie Z, Li S, Self S.","Stat Med. 2012 Dec 10;31(28):3748-59. doi: 10.1002/sim.5446. Epub 2012 Jul 5.","Huang Y","Stat Med","2012","2012/07/06","PMC4087038","NIHMS423357","10.1002/sim.5446"
"20072667","Simultaneous Evaluation of the Magnitude and Breadth of a Left and Right Censored Multivariate Response, with Application to HIV Vaccine Development","Huang Y, Gilbert PB, Montefiori DC, Self SG.","Stat Biopharm Res. 2009 Feb 1;1(1):81-91. doi: 10.1198/sbr.2009.0008.","Huang Y","Stat Biopharm Res","2009","2010/01/15","PMC2805400","NIHMS152082","10.1198/sbr.2009.0008"
